136 related articles for article (PubMed ID: 15737335)
1. Synthesis and initial characterization of FGFR3 transmembrane domain: consequences of sequence modifications.
Iwamoto T; You M; Li E; Spangler J; Tomich JM; Hristova K
Biochim Biophys Acta; 2005 Mar; 1668(2):240-7. PubMed ID: 15737335
[TBL] [Abstract][Full Text] [Related]
2. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
Li E; You M; Hristova K
Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
[TBL] [Abstract][Full Text] [Related]
3. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Li E; You M; Hristova K
J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
[TBL] [Abstract][Full Text] [Related]
4. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M; Chen L; Hristova K
J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
[TBL] [Abstract][Full Text] [Related]
5. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
6. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
Li E; Hristova K
Biochemistry; 2006 May; 45(20):6241-51. PubMed ID: 16700535
[TBL] [Abstract][Full Text] [Related]
7. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
Peng WC; Lin X; Torres J
Protein Sci; 2009 Feb; 18(2):450-9. PubMed ID: 19165726
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
He L; Shobnam N; Hristova K
Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
[TBL] [Abstract][Full Text] [Related]
9. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
[TBL] [Abstract][Full Text] [Related]
10. The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.
You M; Li E; Hristova K
Biochemistry; 2006 May; 45(17):5551-6. PubMed ID: 16634636
[TBL] [Abstract][Full Text] [Related]
11. Role of juxtamembrane and transmembrane domains in the mechanism of natriuretic peptide receptor A activation.
Parat M; Blanchet J; De Léan A
Biochemistry; 2010 Jun; 49(22):4601-10. PubMed ID: 20214400
[TBL] [Abstract][Full Text] [Related]
12. The composition rather than position of polar residues (QxxS) drives aspartate receptor transmembrane domain dimerization in vivo.
Sal-Man N; Gerber D; Shai Y
Biochemistry; 2004 Mar; 43(8):2309-13. PubMed ID: 14979727
[TBL] [Abstract][Full Text] [Related]
13. Nuclear trafficking of FGFR1: a role for the transmembrane domain.
Myers JM; Martins GG; Ostrowski J; Stachowiak MK
J Cell Biochem; 2003 Apr; 88(6):1273-91. PubMed ID: 12647309
[TBL] [Abstract][Full Text] [Related]
14. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
[TBL] [Abstract][Full Text] [Related]
15. Polar residue tagging of transmembrane peptides.
Melnyk RA; Partridge AW; Yip J; Wu Y; Goto NK; Deber CM
Biopolymers; 2003; 71(6):675-85. PubMed ID: 14991677
[TBL] [Abstract][Full Text] [Related]
16. Role of dimerization efficiency of transmembrane domains in activation of fibroblast growth factor receptor 3.
Volynsky PE; Polyansky AA; Fakhrutdinova GN; Bocharov EV; Efremov RG
J Am Chem Soc; 2013 Jun; 135(22):8105-8. PubMed ID: 23679838
[TBL] [Abstract][Full Text] [Related]
17. Arginine mutations within a transmembrane domain of Tar, an Escherichia coli aspartate receptor, can drive homodimer dissociation and heterodimer association in vivo.
Sal-Man N; Shai Y
Biochem J; 2005 Jan; 385(Pt 1):29-36. PubMed ID: 15330757
[TBL] [Abstract][Full Text] [Related]
18. Retention of native-like oligomerization states in transmembrane segment peptides: application to the Escherichia coli aspartate receptor.
Melnyk RA; Partridge AW; Deber CM
Biochemistry; 2001 Sep; 40(37):11106-13. PubMed ID: 11551208
[TBL] [Abstract][Full Text] [Related]
19. FGFR3 unliganded dimer stabilization by the juxtamembrane domain.
Sarabipour S; Hristova K
J Mol Biol; 2015 Apr; 427(8):1705-14. PubMed ID: 25688803
[TBL] [Abstract][Full Text] [Related]
20. The role of individual amino acids in the dimerization of CR4 and ACR4 transmembrane domains.
Stokes KD; Rao AG
Arch Biochem Biophys; 2010 Oct; 502(2):104-11. PubMed ID: 20655866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
